Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
03/2010
03/24/2010CN101678026A 3, 6-disubstituted-imidazo [1, 2-B] pyridazines and 3, 5-disubstituted pyrazolo[1, 5-A] pyrimidines as phosphatidylinositol-3-kinase inhibitors
03/24/2010CN101678022A 5-cyan0-4- (pyrrolo [2, 3b] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors
03/24/2010CN101677984A Use of dimiracetam in the treatment of chronic pain
03/24/2010CN101677973A Composition comprising terpene compounds and methods for inhibiting nerve transmission
03/24/2010CN101677956A Benefit agent containing delivery particle
03/24/2010CN101676401A Scorpion peptide and preparation method
03/24/2010CN101676299A Peptides and/or proteins and use thereof for the production of a therapeutic and/or prophylactic medicament
03/24/2010CN101676279A Preparation method of zedoary cyclic diolefine
03/24/2010CN101675981A Paste agent for treating low back pain
03/24/2010CN101675968A Pharmaceutical composition for treating lumbocrural pain and its preparation method
03/24/2010CN101675964A externally-applied traditional Chinese medicine composition for treating headache
03/24/2010CN101675963A An externally-applied Zhengtong liquid
03/24/2010CN101675958A A traditional Chinese medicine for treating traumatic injury
03/24/2010CN101675946A Application of a traditional Chinese medicine in preparing a medicine for reducing inflammatory reaction after PCI
03/24/2010CN101675942A Honghuoma extract and its preparation method and application
03/24/2010CN101675927A therapeutic molecules and methods-1
03/24/2010CN101675923A New usage of zedoary cyclic diolefine
03/24/2010CN100595211C Angiopoietin-2 specific binding agents
03/24/2010CN100595198C Zedoary cyclo-diolefine and its derivatives preparation method and use
03/24/2010CN100594930C Medicinal composition using anterior pituitary adrenal cortical extract as main component, and its preparation method and use
03/24/2010CN100594911C Medicine composition and use
03/24/2010CN100594897C Cannabinoid liquid formulations for mucosal amdinistration
03/23/2010US7683164 Nucleic acid derivatives
03/23/2010US7683094 2-(2-((2R)-2-heptylaminomethyl-5-oxopyrrolidin-1-yl)ethylthio)-1,3-thiazole-4-carboxylic acid; EP2 and/or EP4 receptor agonist; immune disease; antiallergens; alopecia; dysmenorrhea; erectile dysfuncction; antiarthritic agents; liver, respiratory, vascular, urogenital disorder
03/23/2010US7683078 Neuronal disorders, autoimmune diseases, cancer, cardiovascular diseases; such as 4-Chloro-N-{5-[1-(4-trifluoromethyl-benzyl)-piperidin-3-ylsulfamoyl]-25 thiophen-2-ylmethyl)-benzamide
03/23/2010US7683074 Antiinflammatory agents; antiallergens; neurodegrative disease ; autoimmune disease; antiarthritic agents
03/23/2010US7683068 Emesis, urinary incontinence, depression, and anxiety; substance P inhibitors; 5-{1-[3,5-bis(Trifluoromethyl)phenyl]ethoxy}-4-(4-fluorophenyl)octahydro-1H-isoindole
03/23/2010US7682635 Aqueous dispersions of nanometric or micrometric particles for encapsulating chemical compounds
03/23/2010US7682623 Pharmaceutical composition for topical application
03/23/2010US7682387 Drug-delivery endovascular stent and method for treating restenosis
03/23/2010CA2446059C Production and use of a polar lipid-rich fraction containing stearidonic acid and gamma linolenic acid from plant seeds and microbes
03/23/2010CA2397594C Ethanol solvate of (-)-cis-2-(2-chlorophenyl)-5,7-dihydroxy-8[4r-(3s-hydroxy-1-methyl)piperidinyl]-4h-1-benzopyran-4-one
03/23/2010CA2389767C Quinazoline derivatives as vegf inhibitors
03/23/2010CA2380951C Pharmaceutical compositions for oral and topical administration
03/23/2010CA2358457C Topical composition comprising n-acetylaldosamines or n-acetylamino acids
03/23/2010CA2346869C Phospholipid derivatives of non-steroidal anti-inflammatory drugs
03/23/2010CA2309639C Small peptides and methods for treatment of asthma and inflammation
03/23/2010CA2203655C Tumor necrosis factor-gamma
03/23/2010CA2201106C Anti-inflammatory factor, method of isolation, and use
03/23/2010CA2149818C Combination of necrosis-inducing substances with substances which are activated by necroses for the selective therapy of tumors and inflammatory disorders
03/18/2010WO2010030979A2 Targeting pathogenic monocytes
03/18/2010WO2010030976A2 Methods and compositions for inhibiting atherosclerosis and vascular inflammation
03/18/2010WO2010030891A2 Aryl guanidine f1f0-atpase inhibitors and related methods
03/18/2010WO2010030757A2 Aminopyrimidine inhibitors of histamine receptors for the treatment of disease
03/18/2010WO2010030681A2 Therapeutic agents for the treatment of disorders causing the sensation of suffocation
03/18/2010WO2010030395A2 Withaferin a analogs and uses thereof
03/18/2010WO2010029996A1 Pharmaceutical composition
03/18/2010WO2010029995A1 Therapeutic agent for pain
03/18/2010WO2010029986A1 Glucocorticoid receptor agonist comprising novel 1,2,3,4-tetrahydroquinoxaline derivative containing phenyl group having sulfonic acid ester structure introduced therein as substituent
03/18/2010WO2010029938A1 Novel crystal forms of 4-(2-aminopyridin-4-yl)-3-(4–fluoro- phenyl)-1-(1,4,5,6-tetrahydro-6-oxopyridazin-3-yl)-1h-pyra-zole methanesulfonate and process for production of same
03/18/2010WO2010029497A1 Treatment of endometriosis
03/18/2010WO2010028596A1 The pharmaceutical composition containing ferulic acid and matrine compounds, the preparation and the use thereof
03/18/2010WO2010010394A3 Local pharmaceutical compositions comprising an extract of spilanthes
03/18/2010WO2010010288A3 Alkyl thiazole carbamate derivatives, preparation thereof, and use thereof as faah enzyme inhibitors
03/18/2010WO2009155116A9 Methods of reducing pain and inflammation
03/18/2010WO2009130615A3 Use of deuterium oxide as an elastase inhibitor
03/18/2010WO2009129464A4 Method for treating acute pain with a formulated drug depot in combination with a liquid formulation
03/18/2010WO2009129456A4 Alpha adrenergic receptor agonists for treatment of inflammatory diseases
03/18/2010WO2008154898A3 Preparation for the treatment of equine laminitis
03/18/2010US20100069491 Lipid-amino acid conjugates and methods of use
03/18/2010US20100069490 Composition for a pharmaceutical treatment based on triethyl citrate and adapalene
03/18/2010US20100069489 L-threonine derivatives of high therapeutic index
03/18/2010US20100069484 SIGMA(s)-RECEPTOR LIGANDS WITH ANTI-APOPTOTIC AND/OR PRO-APOPTOTIC PROPERTIES OVER CELLULAR BIOCHEMICAL MECHANISMS, WITH NEUROPROTECTIVE, ANTI-CANCER, ANTI-METASTATIC AND ANTI-(CHRONIC) INFLAMMATORY ACTION
03/18/2010US20100069483 Dual inhibition of cyclooxygenase-2 and carbonic anhydrase
03/18/2010US20100069473 Inhibitors Of IKK-Beta Serine-Threonine Protein Kinase
03/18/2010US20100069466 Compositions and Methods for the Systemic Treatment of Arthritis
03/18/2010US20100069457 Naphthalene Derivatives Used As EP4 Receptor Agonists
03/18/2010US20100069444 Phenathrenone compounds, compositons and methods
03/18/2010US20100069443 Compound with benzamide skeleton having cyclooxygenase-1 (cox-1)-selective inhibitory activity
03/18/2010US20100069438 Anesthesia induction and maintenance drug
03/18/2010US20100069417 Novel phenyl(4-phenylpyrimidin-2-yl)amine derivatives, their preparation, as medicaments, pharmaceutical compositions and in particular as ikk inhibitors
03/18/2010US20100069407 CXCR2 inhibitors
03/18/2010US20100069400 Methods for treating inflammation and related conditions
03/18/2010US20100069392 Combination of HMG-COA Reductase Inhibitors with Phosphodiesterase 4 Inhibitors for the Treatment of Inflammatory Pulmonary Disease
03/18/2010US20100069367 LXR and FXR Modulators
03/18/2010US20100069361 Fused Thiazole Derivatives as Kinase Inhibitors
03/18/2010US20100069354 7-azaindole derivatives and their use in the inhibition of c-jun n-terminal kinase
03/18/2010US20100069348 Novel compounds as cannabinoid receptor ligands
03/18/2010US20100069313 Novel powders based on vegetation water from olive oil production
03/18/2010US20100069297 Selective Inhibition of TLR4 Signaling
03/18/2010US20100069296 Use of somatostatin analogs in cluster headache
03/18/2010US20100068312 Formulation for fever reducing treatment and a method and kit for using thereof
03/18/2010US20100068288 Mixtures or organic compounds for the treatment of airway diseases
03/18/2010US20100068282 Preparation of pharmaceutical compositions
03/18/2010US20100068276 Multiparticulates of spray-coated drug and polymer on a meltable core
03/18/2010US20100068212 Targeting pathogenic monocytes
03/18/2010US20100068200 Methods and Compositions for Inhibiting Atherosclerosis and Vascular Inflammation
03/18/2010US20100068180 Novel methods for modulating inflammatory and/or immune responses
03/18/2010US20100068177 Methods of organ regeneration
03/18/2010US20100068136 Anti-CD19 Antibodies
03/18/2010CA2737056A1 Targeting pathogenic monocytes
03/18/2010CA2736554A1 Novel crystal forms of 4-(2-aminopyridin-4-yl)-3-(4-fluorophenyl)-1-(1,4,5,6-tetrahydro-6-oxopyridazin-3-yl)-1h-pyrazole methanesulfonate and methods for their preparation
03/18/2010CA2735417A1 Glucocorticoid receptor agonist comprising novel 1,2,3,4-tetrahydroquinoxaline derivatives containing phenyl group having sulfonic acid ester structure introduced therein as substituent
03/18/2010CA2735369A1 Heterocyclic inhibitors of histamine receptors for the treatment of disease
03/18/2010CA2735368A1 Aminopyrimidine inhibitors of histamine receptors for the treatment of disease
03/18/2010CA2734309A1 Preparation and usage of a pharmaceutical composition containing ferulic acid and matrine compounds
03/17/2010EP2163554A1 Pyrimidodiazepinone derivative
03/17/2010EP2163253A1 Extracts from the plant hornstedtia scyphifera and immnunosuppressive effects thereof
03/17/2010EP2163241A1 Pharmaceutical compositions for the coordinated delivery of NSAIDs
03/17/2010EP2162470A2 C3b antibodies and methods for the prevention and treatment of complement- associated disorders
1 ... 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 ... 1272